Apathy
Information
- Disease name
- Apathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04051151 | Completed | N/A | Move to Improve Physical Activity in Parkinson's Disease | August 26, 2019 | December 1, 2023 |
| NCT00495820 | Completed | Phase 4 | Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study | August 2007 | June 2010 |
| NCT00548652 | Completed | N/A | Role of Apathy in the Effectiveness of Weight Loss Interventions | August 2007 | May 2009 |
| NCT00767091 | Completed | Phase 3 | Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia | March 2009 | January 2012 |
| NCT02496312 | Completed | N/A | Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated. | July 10, 2015 | October 2, 2015 |
| NCT02765178 | Completed | Apathy in Tourette Syndrome and Changes in Quality of Life | April 2016 | April 2017 | |
| NCT04573712 | Completed | N/A | The Effects of Apathy on Different Forms of Fatigue | January 14, 2021 | December 21, 2021 |
| NCT03141944 | Completed | Evolution of Hypodopaminergic Syndrome in Early Parkinson's Disease | February 23, 2017 | March 11, 2020 | |
| NCT00844090 | Completed | N/A | The Role of Apathy in Glycemic Control | July 2009 | October 2012 |
| NCT01117181 | Completed | Phase 2 | Apathy in Dementia Methylphenidate Trial (ADMET) | June 2010 | August 2012 |
| NCT01172145 | Completed | Phase 3 | Treatment of Apathy in Alzheimer's Disease With Modafinil | July 2005 | September 2007 |
| NCT01481558 | Completed | Phase 2 | Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease | January 2012 | May 2012 |
| NCT05808530 | Completed | N/A | Cognitive Stimulation Therapy | May 1, 2023 | December 30, 2023 |
| NCT01794195 | Completed | N/A | Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres Tracking | February 2013 | December 2013 |
| NCT00456820 | Completed | Phase 4 | Wellbutrin XL Effects on SSRIs Induced Changes | July 2004 | November 2007 |
| NCT01914965 | Completed | Phase 2 | Apathy Cure Through Bupropion in Huntington's Disease | June 2012 | May 2014 |
| NCT02190084 | Completed | Phase 4 | Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia | May 2014 | July 2019 |
| NCT02346201 | Completed | Phase 3 | Apathy in Dementia Methylphenidate Trial 2 | January 2016 | July 15, 2020 |
| NCT05232877 | Enrolling by invitation | N/A | Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment | April 5, 2022 | October 4, 2025 |
| NCT06184165 | Not yet recruiting | N/A | Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation | March 1, 2024 | November 1, 2028 |
| NCT05877885 | Not yet recruiting | N/A | Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics | August 1, 2024 | December 2028 |
| NCT05669170 | Not yet recruiting | Phase 2 | Methylphenidate for Apathy in Veterans With Parkinson's Disease | January 2024 | June 2028 |
| NCT05649176 | Recruiting | N/A | Lifestyle Intervention for Improving Insulin Resistance and Concern for Health | February 13, 2023 | May 2025 |
| NCT03590327 | Recruiting | N/A | Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment | November 1, 2018 | October 31, 2024 |
| NCT04757220 | Recruiting | N/A | Multidimensional Apathy in Psychiatric Pathologies. | January 5, 2022 | March 1, 2025 |
| NCT04917237 | Recruiting | Non-disabling Ischemic Cerebrovascular Event With Apathy | July 10, 2021 | June 10, 2024 | |
| NCT05505019 | Recruiting | N/A | Targeting Apathy With Music in Parkinson's Disease | February 9, 2022 | October 1, 2025 |
| NCT05878457 | Recruiting | Phase 1 | Accelerated rTMS for Post-Stroke Apathy | December 1, 2023 | May 30, 2025 |
| NCT05182151 | Terminated | Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease. | July 29, 2022 | December 1, 2023 | |
| NCT02915484 | Terminated | N/A | Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy | June 2016 | June 2017 |
| NCT01825577 | Terminated | Phase 4 | Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia. | November 2012 | February 2015 |
| NCT04781179 | Unknown status | N/A | Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia | February 22, 2022 | September 2023 |
| NCT04793438 | Unknown status | N/A | Motive-specific Intervention for Negative Symptoms in Schizophrenia | January 1, 2021 | June 30, 2022 |
| NCT01689181 | Unknown status | Apathy in Schizophrenia | June 2012 | September 2013 | |
| NCT02190019 | Unknown status | Phase 4 | Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study | April 2014 | July 2016 |
| NCT01885806 | Unknown status | Phase 2 | Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease | June 2013 | December 2015 |
| NCT03190681 | Unknown status | Early Phase 1 | Motivation and Methylphenidate | July 1, 2017 | September 30, 2018 |
| NCT03272230 | Unknown status | N/A | Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System | September 6, 2017 | February 28, 2022 |
| NCT03293537 | Unknown status | N/A | Dementia Associated Apathy. | October 30, 2017 | July 31, 2019 |
| NCT03998852 | Unknown status | Phase 3 | In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy. | April 13, 2021 | May 13, 2022 |
| NCT02786667 | Unknown status | Phase 3 | Non Motors Aspects in De Novo Parkinson's Disease | June 2012 | December 2017 |
| NCT01765257 | Unknown status | Phase 4 | Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study | June 2013 | March 2015 |
| NCT00792662 | Withdrawn | Phase 4 | Improving Function, Quality of Life, Glycemia in Diabetics With Dementia | November 18, 2008 | December 20, 2011 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000741